Who Just RaisedGrasonville, MD · Health Care · Form D filed Aug 25, 2026
OS Therapies Inc raised $5M
OS Therapies Inc is a biotechnology company based in Grasonville, Maryland. In a Form D filed with the SEC on August 25, 2026, it reported raising $5,000,000 from 10 investors as part of an offering of up to $10,000,000. The first sale in the offering took place on August 10, 2026.
- 12th Form D since 2019. Earlier new notices: Jul 16, 2026 · Mar 6, 2026 · Jan 20, 2026 · Sep 10, 2025 · Jul 16, 2025 · Jan 22, 2025 and more. All filings on EDGAR
- Still raising. $5M of the $10M offering was still unsold at filing.
$30.9M raised since 2020
11 Form D offerings, as reported to the SEC, the first in May 1, 2020. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 25, 2026 | $5M | $10M | 10 |
| Jul 16, 2026 | $1.6M | $9.3M | 1 |
| Mar 6, 2026 | $2M | $2M | 9 |
| Jan 20, 2026 | $3.5M | $7.5M | 9 |
| Sep 10, 2025 | $3.8M | $3.8M | 10 |
| Jul 16, 2025 | $4.2M | $4.2M | 27 |
| Jan 22, 2025 | $7.1M | $10M | 34 |
| Dec 14, 2023 | $700K | $2M | 3 |
and 3 earlier.
Placement agents: Ceros Financial Services, Inc., Arcadia Securities, LLC, Noble Capital Markets, Inc.
Lead score
28 out of 100
still raising budget to spend website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- ostherapies.com
- Amount raised
- $5,000,000
- Offering size
- $10,000,000
- Investors so far
- 10
- First sale
- August 10, 2026
- Securities offered
- Equity, Debt, Options or warrants, Securities issuable on exercise or conversion
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Grasonville, Maryland
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $5,000,000 | $10,000,000 | 10 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 24, 2026 · Health Care funding in Maryland · August 2026 funding report
Similar raises
Kaigene, Inc.
Rockville, MD · filed Oct 142nd Form D since 2022Still raising
ColoWatch, Inc.
Gaithersburg, MD · filed Oct 8
Virtual colonoscopy screening with no sedation, standardized protocols, secure cloud delivery, advanced 3D visualization, and expert radiologist interpretation.
First Form DStill raising
Templar Nova, Inc.
Rockville, MD · filed Oct 7First Form D
Monocacy Therapeutics Inc.
Monrovia, MD · filed Oct 75th Form D since 2026
Seraxis Holdings, Inc.
Germantown, MD · filed Sep 24
Seraxis is a private biotechnology company that has developed a novel cell and immune-evasion technology with the goal to reverse Type 1 Diabetes.
2nd Form D since 2021
Aromha, Inc.
Potomac, MD · filed Sep 243rd Form D since 2025
Uvantis Therapeutics, Inc.
Columbia, MD · filed Sep 23First Form DStill raising
Functional Longevity Labs, Inc.
Easton, MD · filed Sep 21First Form DStill raising